Finance

Lists
Why is HNSA down 2,75%?
Dive Deeper
HNSA:STO
Hansa Biopharma AB
33,18 SEK
-2,75%
(-0,94) 1D
2 հոկ, 17:29:56 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
34,10 SEK
High
34,40 SEK
Low
33,00 SEK
Mkt. cap
3,38 մլրդ
Avg. vol.
624,11 հզր
Volume
0,00
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 մլն
No. of employees
131
Open
34,10 SEK
High
34,40 SEK
Low
33,00 SEK
Mkt. cap
3,38 մլրդ
Avg. vol.
624,11 հզր
Volume
0,00
52-wk high
48,22 SEK
52-wk low
23,52 SEK
EPS
-7,90 SEK
Shares outstanding
101,76 մլն
No. of employees
131
News stories
From web sources and news partners
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees131
Founded2007
Headquarters-
Sector-
Websitehansabiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
30,80 մլն
75,99 մլն
34,57 մլն
48,10 մլն
Cost of goods sold
20,11 մլն
24,66 մլն
13,78 մլն
22,33 մլն
Cost of revenue
20,11 մլն
24,66 մլն
13,78 մլն
22,33 մլն
Research and development expenses
70,21 մլն
74,43 մլն
57,34 մլն
67,87 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,41 մլն
101,62 մլն
105,56 մլն
118,93 մլն
Operating expense
160,41 մլն
176,02 մլն
162,90 մլն
186,83 մլն
Total operating expenses
180,52 մլն
200,67 մլն
176,68 մլն
209,16 մլն
Operating income
-149,71 մլն
-124,68 մլն
-142,11 մլն
-161,06 մլն
Other non operating income
-
-
1,38 մլն
-30,53 մլն
EBT including unusual items
-147,56 մլն
-169,50 մլն
-195,87 մլն
-259,86 մլն
EBT excluding unusual items
-147,56 մլն
-169,50 մլն
-195,87 մլն
-259,86 մլն
Income tax expense
693,00 հզր
396,00 հզր
453,00 հզր
677,00 հզր
Effective tax rate
-0,47%
-0,23%
-0,23%
-0,26%
Other operating expenses
1,79 մլն
-34,00 հզր
-
28,00 հզր
Net income
-148,26 մլն
-169,90 մլն
-196,32 մլն
-260,54 մլն
Net profit margin
-481,29%
-223,58%
-567,89%
-541,71%
Earnings per share
-1,75
-1,62
-1,93
-2,26
Interest and investment income
10,28 մլն
-
2,55 մլն
3,20 մլն
Interest expense
-10,23 մլն
-208,06 մլն
-28,90 մլն
-58,48 մլն
Net interest expenses
49,00 հզր
-208,06 մլն
-26,35 մլն
-55,27 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-149,07 մլն
-124,05 մլն
-141,48 մլն
-149,39 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps